These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study. Lu S; Hill J; Fillit H Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386 [TBL] [Abstract][Full Text] [Related]
3. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Saxena G; Singh SP; Agrawal R; Nath C Eur J Pharmacol; 2008 Mar; 581(3):283-9. PubMed ID: 18234183 [TBL] [Abstract][Full Text] [Related]
4. [Current antidementive therapy]. Perneczky R; Kurz A MMW Fortschr Med; 2004 May; 146 Spec No 2():53-6. PubMed ID: 15376702 [TBL] [Abstract][Full Text] [Related]
5. Recommendations for best practices in the treatment of Alzheimer's disease in managed care. Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. Rösler M Int J Clin Pract Suppl; 2002 Jun; (127):20-36. PubMed ID: 12139365 [TBL] [Abstract][Full Text] [Related]
8. Evidence that the clinical effects of cholinesterase inhibitors are related to potency and targeting of action. Poirier J Int J Clin Pract Suppl; 2002 Jun; (127):6-19. PubMed ID: 12139368 [TBL] [Abstract][Full Text] [Related]
9. Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease. Haywood WM; Mukaetova-Ladinska EB Am J Geriatr Pharmacother; 2006 Sep; 4(3):273-86. PubMed ID: 17062329 [TBL] [Abstract][Full Text] [Related]
10. Study of neuroprotection of donepezil, a therapy for Alzheimer's disease. Akasofu S; Kimura M; Kosasa T; Sawada K; Ogura H Chem Biol Interact; 2008 Sep; 175(1-3):222-6. PubMed ID: 18571635 [TBL] [Abstract][Full Text] [Related]
11. [Dementing disorders. What benefits do the new anti-dementia drugs have?]. Ihl R MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846 [TBL] [Abstract][Full Text] [Related]
12. A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia. Cummings J; Winblad B Expert Rev Neurother; 2007 Nov; 7(11):1457-63. PubMed ID: 17997695 [TBL] [Abstract][Full Text] [Related]
13. Rivastigmine: new product. No better than donepezil. Prescrire Int; 1999 Apr; 8(40):47-8. PubMed ID: 10848060 [TBL] [Abstract][Full Text] [Related]
14. Drug therapy of dementia in elderly patients. A review. Olsen CE; Poulsen HD; Lublin HK Nord J Psychiatry; 2005; 59(2):71-7. PubMed ID: 16195103 [TBL] [Abstract][Full Text] [Related]
15. [Are the new drugs for treatment of Alzheimer's disease useful?]. Carnero Pardo C Rev Neurol; 2001 Jan 16-31; 32(2):176-9. PubMed ID: 11299483 [TBL] [Abstract][Full Text] [Related]